LFVN Form 4: CMO Disposes 1,835 Shares for $9.56; 150,088 Remain

Rhea-AI Filing Summary

Julie Boyster, listed as the Chief Marketing Officer of Lifevantage Corp (LFVN), reported a sale of company common stock on 10/01/2025. The Form 4 shows she disposed of 1,835 shares at a price of $9.56 per share. After the transaction she beneficially owned 150,088 shares, held directly. The filing was signed by a power of attorney on 10/03/2025. The form is a standard Section 16 filing reporting insider changes in beneficial ownership and contains no additional remarks or derivative transactions.

Positive

• Transparent disclosure of insider transaction with precise share count and price
• Substantial remaining ownership of 150,088 shares retained after sale

Negative

• Insider sale of 1,835 shares at $9.56 could be viewed negatively by some investors

Insights

Corporate Governance Analyst

Insider sale reported: CMO sold 1,835 shares at $9.56, retaining 150,088.

The Form 4 documents a single non-derivative sale by Julie Boyster on 10/01/2025. The filing lists the sale amount, price, and resulting direct ownership without additional commentary or related-party transactions.

This is routine Section 16 disclosure; it records a precise change in holdings but does not, on its face, disclose motive, hedging, or any derivative activity. The signature by power of attorney on 10/03/2025 confirms timely attestation to the reported facts.

Insider Trade Summary

Net Seller: 1,835 shares

Net Sell 1 txn

Insider Boyster Julie

Role Chief Marketing Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,835	$9.56	$18K

Holdings After Transaction: Common Stock — 150,088 shares (Direct)

FAQ

What did Lifevantage (LFVN) insider Julie Boyster report on Form 4?

The Form 4 reports that Julie Boyster sold 1,835 shares of Lifevantage common stock on 10/01/2025 at $9.56 per share and after the sale beneficially owned 150,088 shares.

What position does the reporting person hold at LFVN?

The filing identifies the reporting person as the company's Chief Marketing Officer.

How was the Form 4 signed and when?

The Form 4 was signed by Alissa Neufeld as power of attorney for Julie Boyster on 10/03/2025.

Does the Form 4 show any derivative transactions for LFVN by this filer?

No. The filing contains only a non-derivative common stock sale and no derivative securities are reported.

How many shares did Julie Boyster own after the reported transaction?

Following the reported sale, she beneficially owned 150,088 shares, held directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/03/2025 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Boyster Julie

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		F		1,835	D	$9.56	150,088	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Julie Boyster	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.